Edmund Dunn

Insider Reports History

Location
Boston, MA
Signature
/s/ Phil Nickson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edmund Dunn:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Principal Accounting Officer Common Stock 22,554 $405,069 $17.96 04 Mar 2026 Direct
Monte Rosa Therapeutics, Inc. Principal Accounting Officer Stock Option (Right to Buy) 0 02 Mar 2026 Direct

Insider Reports Filed by Edmund Dunn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLUE Monte Rosa Therapeutics, Inc. 04 Mar 2026 1 -$2,496 4 Principal Accounting Officer 05 Mar 2026, 17:24
GLUE Monte Rosa Therapeutics, Inc. 27 Feb 2026 6 -$120,249 4 Principal Accounting Officer 02 Mar 2026, 17:02
GLUE Monte Rosa Therapeutics, Inc. 05 Jan 2026 1 -$15,762 4 Principal Accounting Officer 05 Jan 2026, 16:04
GLUE Monte Rosa Therapeutics, Inc. 03 Jun 2025 1 -$9,174 4 Principal Accounting Officer 04 Jun 2025, 16:15
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2025 2 $0 4 Principal Accounting Officer 06 Jan 2025, 16:15
GLUE Monte Rosa Therapeutics, Inc. 05 Jul 2024 1 -$6,166 4 Principal Accounting Officer 09 Jul 2024, 16:15
GLUE Monte Rosa Therapeutics, Inc. 03 Jun 2024 1 -$4,876 4 Principal Accounting Officer 05 Jun 2024, 16:10
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2024 2 $0 4 Principal Accounting Officer 04 Jan 2024, 16:15
GLUE Monte Rosa Therapeutics, Inc. 08 Aug 2023 0 $0 3 Principal Accounting Officer 18 Aug 2023, 16:00